Share on StockTwits

Physicians Realty Trust (NYSE:DOC) Director Stanton D. Anderson bought 3,600 shares of the company’s stock on the open market in a transaction that occurred on Friday, May 30th. The stock was purchased at an average price of $13.75 per share, with a total value of $49,500.00. Following the transaction, the director now directly owns 34,142 shares in the company, valued at approximately $469,453. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of Physicians Realty Trust (NYSE:DOC) traded up 0.36% on Monday, hitting $13.86. 371,985 shares of the company’s stock traded hands. Physicians Realty Trust has a 52-week low of $11.00 and a 52-week high of $14.00. The stock’s 50-day moving average is $13.30 and its 200-day moving average is $12.88. The company’s market cap is $295.2 million.

Physicians Realty Trust (NYSE:DOC) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by $0.05. Analysts expect that Physicians Realty Trust will post $0.88 EPS for the current fiscal year.

A number of analysts have recently weighed in on DOC shares. Analysts at Bank of America initiated coverage on shares of Physicians Realty Trust in a research note on Monday. They set a “buy” rating and a $14.25 price target on the stock. Analysts at Wunderlich raised their price target on shares of Physicians Realty Trust from $14.75 to $15.50 in a research note on Wednesday, May 21st. They now have a “buy” rating on the stock. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $15.03.

Physicians Realty Trust is a real estate investment trust (NYSE:DOC).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.